The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Headline
The Food and Drug Administration has identified Class I recalls of two products: certain platelet factor 4 radioimmunoassay products by Instrumentation…
Headline
The AHA will host a webinar Nov. 3 at 1 p.m. ET to discuss the cybersecurity, compliance and operational risks that can emerge when end-of-life technology is…
Headline
The Department of Justice Oct. 13 announced a series of actions disrupting a scheme by the North Korean government that involved placing remote IT workers in U…
Headline
A joint advisory issued Oct. 20 by U.S. and international agencies warns of recent activity by the SafePay Ransomware group. The group has been active since…
Headline
Two critical vulnerabilities have been discovered in Hypertext Preprocessor, or PHP, a widely-used open-source scripted language for web development, its…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, and Brett Leatherman, assistant director of the FBI Cyber Division, break down Operation Riptide,…